Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The objective of the study is to evaluate an ultraportable ultrasound device, Hepatoscope, for the non-invasive assessment of hepatic steatosis in patients with metabolic-dysfunction associated liver diseases (MASLD), by comparing its measurements with current diagnostic modalities, such as MRI-PDFF.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Adult patient below 80 yo
• Patients with MASLD/MASH recruited in interventional trials requiring MRI PDFF +/- MRE per interventional protocol, OR
• Patients with MASLD/MASH recruited in prospective cohorts requiring MRI PDFF +/- MRE per interventional protocol, OR
• Patients referred to MRI-PDFF or MRE.
• Patients who consented in written to participate in the study
• Patients with ongoing social security coverage
Locations
Other Locations
France
University Hospital Angers
RECRUITING
Angers
Beaujon University Hospital
RECRUITING
Clichy
Pitie Salpetriere University Hospital
NOT_YET_RECRUITING
Paris
Contact Information
Primary
Jerome Boursier, MD, PhD
jeboursier@chu-angers.fr
+33 2 41 35 31 42
Time Frame
Start Date: 2025-07-24
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 120
Treatments
Experimental: Main cohort
Patients recruited in the study will receive an ultrasound exam with Hepatoscope to collect quantitative measurements related to the severity of liver steatosis.
Related Therapeutic Areas
Sponsors
Leads: E-Scopics